Protocol · Oncology Support
Bladder Cancer Supportive Care Protocol
Vitamin D and Green Tea Extract (EGCG) are the core of this stack, with 6 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Bladder Cancer Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
8 supplements · none graded yet
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file |
|---|---|---|---|---|
| Primary stackThe core of this protocol | ||||
| Vitamin D | Amount listed: 2,000–4,000 IU daily (target 40–60 ng/mL) | Deficiency associated with worse bladder cancer outcomes; supplementation may support immune function | Not graded yet | |
| Green Tea Extract (EGCG) | Amount listed: 250–500 mg EGCG daily | Catechins may have anti-cancer properties; epidemiological studies link green tea consumption to lower bladder cancer risk | Not graded yet | |
| Supporting stackListed as additions to the core | ||||
| Probiotics | Amount listed: 20–50 billion CFU daily multi-strain | May support immune function, especially during intravesical BCG immunotherapy | Not graded yet | |
| Omega-3 Fatty Acids | Amount listed: 2–3 g EPA+DHA daily | Anti-inflammatory effects; may support overall health during cancer treatment | Not graded yet | |
| Selenium | Amount listed: 100–200 mcg daily (do not exceed 400 mcg) | Antioxidant trace element; some studies suggest association with bladder cancer risk | Not graded yet | |
| Vitamin E | Amount listed: 400 IU daily (discuss with oncologist) | Antioxidant; epidemiological data on bladder cancer is mixed | Not graded yet | |
| Curcumin | Amount listed: 500–1,000 mg bioavailable form daily | Anti-inflammatory with preclinical anti-cancer properties; may support overall health | Not graded yet | |
| Vitamin C | Amount listed: 500–1,000 mg daily | Antioxidant support; maintains immune function during treatment | Not graded yet | |
How this protocol works
In plain language
Bladder cancer is the sixth most common cancer, with smoking being the primary risk factor. Treatment depends on whether cancer is non-muscle-invasive (75% of cases) or muscle-invasive. Non-muscle-invasive bladder cancer is typically treated with transurethral resection (TURBT) followed by intravesical therapy (BCG immunotherapy or chemotherapy instilled directly into the bladder). Muscle-invasive cancer often requires radical cystectomy (bladder removal) or radiation. Supplements may provide supportive care during treatment.
CRITICAL: Bladder cancer requires specialized urologic oncology care. Standard treatments (surgery, BCG, chemotherapy, immunotherapy) are essential - supplements do NOT replace medical treatment. Always discuss supplements with your oncology team before starting, as some may interact with treatments. Never delay standard treatment.
Vitamin D* deficiency is common in bladder cancer patients and associated with worse outcomes. Maintaining adequate vitamin D levels supports immune function, which is particularly important during BCG therapy (an immune-based treatment).
Green Tea Extract (EGCG)* contains catechins with potential anti-cancer properties. Epidemiological studies show green tea consumption is associated with lower bladder cancer risk. It may also help prevent recurrence.
Probiotics* support gut and immune health. There is interest in whether probiotics might enhance BCG therapy response, though evidence is preliminary.
Omega-3 Fatty Acids* have anti-inflammatory effects and support overall health during cancer treatment.
Selenium* is an antioxidant trace element with mixed evidence regarding bladder cancer. Some studies suggest lower selenium levels are associated with higher risk.
Vitamin E* is an antioxidant with mixed epidemiological data for bladder cancer. Discuss with your oncologist before use.
Curcumin* has anti-inflammatory properties and is being studied for cancer support, though human data in bladder cancer is limited.
Vitamin C* supports immune function and provides antioxidant protection during treatment.
Expected timeline: These supplements provide ongoing supportive care. Vitamin D levels should be checked and optimized. Surveillance cystoscopy is essential for recurrence monitoring - bladder cancer has high recurrence rates requiring close follow-up.